genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Novel imPACT Isolation Technology Opens Doors to Improved Personalized Therapies
Bioprocessing
Newly Discovered Bacterial Natural Product Pathway Offers Potential for Synthetic Biology
Tech Exclusives
Dogs’ Cancer Genome May Aid Osteosarcoma in Kids
News
Charles River Labs to Open Second CRADL Facility in South San…
News
Zebrafish Screening Platform Boosts Spinal Cord Injury Drug Discovery
Insights
Insights
Gut Microbiome May Alter ALS Progression in Mice
Neuroscience
MS Looks to Transcriptomics for Answers on Neuronal Vulnerability
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Gut Microbiome May Alter ALS Progression in Mice
News
Novel imPACT Isolation Technology Opens Doors to Improved Personalized Therapies
Bioprocessing
Newly Discovered Bacterial Natural Product Pathway Offers Potential for Synthetic Biology
Tech Exclusives
Dogs’ Cancer Genome May Aid Osteosarcoma in Kids
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: Precision Health’s Bloodline Starts with Great Science
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Biosimilars
Biosimilars
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biosimilars
Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal
Biosimilars
Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance” Dispute
Biosimilars
FDA Issues CRL Seeking More Data on Biocon/Mylan Neulasta Biosimilar
Biosimilars
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Biosimilars
After FDA Approval, Amgen–Allergan Cancer Biosimilar Mvasi Faces Launch, Pricing Challenges
Biosimilars
Takeda, Samsung Bioepis Partner to Develop Novel Biologic Therapies
Biosimilars
Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S.
Biosimilars
Merck Wins Tentative FDA Approval for Lusduna
Biosimilars
Daiichi Sankyo Ends Biosimilar Enbrel Partnership with Coherus in Japan
Biosimilars
EC Clears Sandoz’s Erelzi Biosimilar Etanercept Copy of Amgen’s Enbrel
Biosimilars
Sandoz’ Rituximab Biosimilar Rixathon Wins EC Clearance
Biosimilars
Supreme Court’s Sandoz–Amgen Decision Boosts Biosimilars
Biosimilars
Sanofi Partners with JHL to Develop Biosimilars for Chinese Market
Biosimilars
Shire Ends Biosimilar Humira Collaboration with Momenta
Biosimilars
FDA Nixes Sandoz Bid to Market Pegfilgrastim Biosimilar
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
